The formal pharmacokinetic data showing a 33% increase in levothyroxine exposure was studied with oral semaglutide specifically, but injectable formulations of both drugs also slow gastric emptying enough to affect thyroid medication absorption
(This is associative evidence and may reflect confounding by indication, surveillance patterns, and glycaemic differences.) For post-marketing pharmacovigilance, FAERS-based analyses of semaglutide identify multiple safety signals (e.g., gastrointestinal obstruction-related terms, dehydration/volume depletion in some GLP-1RA analyses), but vulvovaginal dryness/infection/discharge/pain are not prominent as labelled risks in the major semaglutide FAERS disproportionality paper retrieved here
Store lyophilized BPC-157 + TB-500 vials at -20C, away from light and moisture
Barcode: 5055534309711(EAN / EAN-13) Brands: MYPROTEIN Countries where sold: France Matching with your preferences Health Nutrition Nutri-Score unknown Missing category and nutrition facts The category of the product must be specified in order to compute the Nutri-Score
Many patients use compounded GLP-1 during the 30-90 day Medicaid review window, then transition to Medicaid coverage once authorized
They measure in units
